Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Winston

Showing results (21-30 of 241) with videos related to

Pageof 25
Sort By:
Current Opinion in HIV and AIDS|April 29, 2025
Cognitive impairment in persons with HIV: changing aetiologies and management strategiesAlan Winston, Andrea Calcagno, Paola Cinque
HIV Clinical Trials|December 23, 2011
Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapyLucy Garvey, Veena Surendrakumar, Alan Winston
Pharmacogenomics|June 7, 2006
The clinical implications of antiretroviral pharmacogenomicsJulie Fox, Marta Boffito, Alan Winston
Current Opinion in Infectious Diseases|November 1, 2005
Host determinants of antiretroviral drug activityMarta Boffito, Alan Winston, Andrew Owen
AIDS (London, England)|March 29, 2017
HIV cure strategies: response to ignore the central nervous system at your patients' perilAlan Winston, Fox Julie, Sarah Fidler
BMJ (Clinical Research Ed.)|April 25, 2015
Drug treatment for adults with HIV infectionMiriam Samuel, Alan Winston, Barry Peters
Current Opinion in Neurology|June 4, 2025
Brain health in HIV: pathogenesis, classification, and treatmentKathryn B Holroyd, Alan Winston, Sam Nightingale
Journal of Neurology, Neurosurgery, and Psychiatry|February 5, 2013
HIV, dementia and antiretroviral drugs: 30 years of an epidemicHadi Manji, H R Jäger, Alan Winston
AIDS Research and Human Retroviruses|August 15, 2009
Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapyLucy J Garvey, Dharani Yerrakalva, Alan Winston
AIDS (London, England)|April 14, 2011
Superior neurocognitive function is associated with central nervous system antiretroviral drug penetration only in regimens containing more than three antiretroviral agentsAlan Winston, Lucy Garvey, Caroline A Sabin
Pageof 25

Showing results (21-30 of 241) with videos related to

Sort By:
Pageof 25
Current Opinion in HIV and AIDS|April 29, 2025
Cognitive impairment in persons with HIV: changing aetiologies and management strategiesAlan Winston, Andrea Calcagno, Paola Cinque
HIV Clinical Trials|December 23, 2011
Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapyLucy Garvey, Veena Surendrakumar, Alan Winston
Pharmacogenomics|June 7, 2006
The clinical implications of antiretroviral pharmacogenomicsJulie Fox, Marta Boffito, Alan Winston
Current Opinion in Infectious Diseases|November 1, 2005
Host determinants of antiretroviral drug activityMarta Boffito, Alan Winston, Andrew Owen
AIDS (London, England)|March 29, 2017
HIV cure strategies: response to ignore the central nervous system at your patients' perilAlan Winston, Fox Julie, Sarah Fidler
BMJ (Clinical Research Ed.)|April 25, 2015
Drug treatment for adults with HIV infectionMiriam Samuel, Alan Winston, Barry Peters
Current Opinion in Neurology|June 4, 2025
Brain health in HIV: pathogenesis, classification, and treatmentKathryn B Holroyd, Alan Winston, Sam Nightingale
Journal of Neurology, Neurosurgery, and Psychiatry|February 5, 2013
HIV, dementia and antiretroviral drugs: 30 years of an epidemicHadi Manji, H R Jäger, Alan Winston
AIDS Research and Human Retroviruses|August 15, 2009
Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapyLucy J Garvey, Dharani Yerrakalva, Alan Winston
AIDS (London, England)|April 14, 2011
Superior neurocognitive function is associated with central nervous system antiretroviral drug penetration only in regimens containing more than three antiretroviral agentsAlan Winston, Lucy Garvey, Caroline A Sabin
Pageof 25